Clinical trial No longer in our active list Interventional Ages 18 to 60

Effects of tart cherry powder on metabolic syndrome

Official title: Impact of 60 Days Powdered Tart Cherry Supplementation on Metabolic Syndrome

Run by Ohio University · NCT05614947 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether taking tart cherry powder can help people with metabolic syndrome improve their heart health and reduce their risk of diabetes.

More Metabolic Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorOhio University
Academic / other
Locations1 site (Athens, Ohio)
Trial IDNCT05614947 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 25-60 who have been diagnosed with metabolic syndrome or meet its diagnostic criteria.

Probably not a fit

Patients currently taking medications for glucose or lipid control, or those with inflammatory conditions, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of powdered tart cherry supplementation on individuals diagnosed with metabolic syndrome, a condition linked to increased risk of cardiovascular disease and type II diabetes. Participants will receive either the tart cherry supplement or a placebo over a 60-day period. The study aims to assess changes in metabolic parameters such as lipid levels, glucose clearance, and inflammation markers. By focusing on dietary interventions, the research seeks to explore the potential benefits of polyphenols found in tart cherries on metabolic health.

Why it matters

Potential benefit: If successful, this study could provide a natural dietary supplement option to help manage metabolic syndrome and reduce associated health risks.

How similar studies have gone: While the specific use of tart cherry supplementation is less common, other studies have shown positive effects of polyphenols on metabolic health, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Have been diagnosed with metabolic syndrome by a physician or meet the diagnostic criteria: Waist circumference greater than 40 inches (men) or greater than 35 inches (women), High blood pressure (greater than 130/80) or taking medication for high blood pressure, High triglycerides (greater than 150 mg/dL) or low HDL (less than 40 for men, less than 50 for women), High fasting blood glucose (100-126 mg/dL) or diagnosed as pre-diabetic
* Age 25-60

Exclusion Criteria:

* currently taking medication for glucose or lipid control, such as metformin and/or statin
* currently using anti-inflammatory medications \& have not used corticosteroids in the last two months
* diagnosed with or currently being treated for an inflammatory condition
* major organ system impairment (heart failure, renal failure, severe impairment of respiratory function)
* currently a smoker or quit less than 12 months ago

Where it's running

  • Ohio University Exercise Physiology Lab
    Athens, Ohio, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.